Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Sybron Tabs Innova Dental Implant Profits For Stronger Sales Force Bite

This article was originally published in The Gray Sheet

Executive Summary

Sybron Dental Specialties will use initial Innova dental implant profits to fund expansion of a dedicated North American sales force after acquiring the business for $43.7 mil

You may also be interested in...



Henry Schein All Smiles About Camlog Dental Implant Alliance, Market Entry

Henry Schein's strategic partnership with Swiss firm Camlog Holding provides an entry into the roughly $400 mil. U.S. dental implant market

Encore Raises Curtain On $750 Mil. Dental Implant Market With BioHorizons

Encore Medical will gain a 5% share of the U.S. dental implant market via a deal to buy BioHorizons for $26 mil. in cash/stock, plus up to $10 mil. in milestones

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT020815

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel